应对腺相关病毒 (AAV) 免疫性在基因疗法应用中的新兴技术
Tatiana Egorova1,2, Anna Starikova1,2, Anna Polikarpova1,2
1Laboratory of Modeling and Therapy of Hereditary Diseases, Institute of Gene Biology Russian Academy of Sciences, 119334 Moscow, Russia.
Pharmaceutics
|November 27, 2025
概括
腺相关病毒载体 (AAV) 是一种革命性的基因疗法. 本综述探讨了克服对AAV的免疫反应的策略,使未来的再注射和更广泛的治疗应用成为可能.
科学领域:
- 基因治疗 基因治疗
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 腺相关病毒载体 (AAV) 是对遗传性疾病的有效基因传递系统.
- 目前的AAV疗法是一次性治疗,面临免疫反应和先前存在的免疫力的挑战.
- 由于免疫反应,未来重新使用AAV基因疗法是不确定的.
研究的目的:
- 审查克服先前存在的和治疗诱导的AAV免疫力的策略.
- 突出解决AAV免疫性对于成功基因治疗的重要性.
- 为开发强大的基于AAV的治疗平台做出贡献.
主要方法:
- 关于AAV免疫和缓解策略的当前文献的综述.
- 病毒载体修饰的分析 (囊体,编码子优化).
- 评估免疫调节方法 (空囊,药物支持).
主要成果:
- 存在多种策略来抵消AAV免疫力,包括载体修饰和免疫抑制.
- 空囊陷和药理干预措施在控制免疫反应方面表现有前途.
- 克服免疫力对于实现重复剂量和扩大AAV治疗应用至关重要.
结论:
- 解决AAV免疫性对于基因治疗的长期成功至关重要.
- 对于有效的AAV再给药,可能需要载体工程和免疫调节的组合.
- 对克服AAV免疫力的进一步研究将推动基因治疗的发展.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K